Essais liés3clinical trials
VilleHallandalelocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05127486

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
Elismetrep Migraine Phase 3 NCT07816367 A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine NOT_YET_RECRUITING
Galcanezumab Migraine Phase 4 NCT05127486 CHALLENGE-MIG — A Study of Galcanezumab (LY2951742) in Adult Participants With Episodic Migraine COMPLETED
Rimegepant Migraine Phase 3 NCT06641466 A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine RECRUITING